|Bid||1.0600 x 2900|
|Ask||1.0800 x 1000|
|Day's range||1.0500 - 1.1500|
|52-week range||0.6300 - 3.8500|
|Beta (5Y monthly)||2.05|
|PE ratio (TTM)||N/A|
|Earnings date||12 Jun 2020|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
The Company has made plans for a smooth transition. Mr. Weinstein is a finance and accounting senior executive with over 30 years of “hands-on” public and private company management, investment banking and private equity investing experience.
Zynex (ZYXI) is likely to maintain the current high on a number of favorable factors.
Abbott (ABT) is upbeat about the latest clearance in its neuromodulation product portfolio.